Trademark: 76311858
Word
KARO BIO
Status
Dead
Status Code
710
Status Date
Friday, October 10, 2014
Serial Number
76311858
Registration Number
3390490
Registration Date
Tuesday, March 4, 2008
Mark Type
1000
Filing Date
Wednesday, September 12, 2001
Published for Opposition
Tuesday, March 23, 2004
Cancellation Date
Friday, October 10, 2014

Trademark Owner History
Karo Bio AB - Original Registrant

Classifications
1 Chemical reagents for scientific or research use, namely, assays for identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances, such as enzymes or receptors, assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor, and tissue culture growth media; chemical preparations for use in medical research, namely, reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances such as enzymes or receptors; assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor; biochemicals for industrial purposes, namely, tissue culture growth media; chemical and biological substances for use in the manufacture of medicinal, pharmaceutical and veterinary products
5 Pharmaceutical preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; pharmaceutical substances, namely dermatological creams for the treatment of skin disorders; veterinary preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; veterinary substances, namely, dermatological creams for use in the treatment of skin disorders, medicinal preparations for the treatment of metabolic disorders such as such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; medicinal substances, namely, dermatological cream for the treatment of skin disorders; medical diagnostic reagents; diagnostic agents for veterinary use; clinical medical reagents, namely, reagents for clinical-chemical tests; diagnostic reagents for clinical or medical laboratory use; vaccines; transdermal drug patches sold with medication for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, stroke, peripheral vascular disease, thromboembolism, retenosis of catheterization or surgical repairs, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; diagnostic kits for medical and veterinary purposes, namely, assays and reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as enzymes and receptors and to identify antibacterial compounds
10 Diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity or biologically active substances, such as receptors and enzymes, and to identify antibacterial compounds
42 Pharmaceutical research services; pharmaceutical advisory services; scientific research project management; scientific and industrial research; medical laboratory services; medical research; provision of medical information; veterinary laboratory services

Trademark Events
Oct 10, 2014
Cancelled Sec. 8 (6-Yr)
Mar 4, 2008
Registered-Principal Register
Jan 30, 2008
1(B) Basis Deleted; Proceed To Registration
Jun 15, 2006
Notice Of Allowance Cancelled
Jan 30, 2008
Review Of Correspondence Complete
Oct 29, 2007
Paper Received
Jun 5, 2006
Teas Delete 1(B) Basis Received
Jan 9, 2006
Extension 3 Granted
Dec 7, 2005
Extension 3 Filed
Dec 7, 2005
Teas Extension Received
Jun 20, 2005
Extension 2 Granted
Jun 13, 2005
Extension 2 Filed
Jun 13, 2005
Teas Extension Received
Dec 22, 2004
Extension 1 Granted
Dec 14, 2004
Extension 1 Filed
Dec 14, 2004
Teas Extension Received
Aug 20, 2004
Case File In Ticrs
Jun 15, 2004
Noa Mailed - Sou Required From Applicant
Mar 23, 2004
Published For Opposition
Mar 3, 2004
Notice Of Publication
Jan 9, 2004
Approved For Pub - Principal Register
Apr 10, 2003
Sec. 44(D) Claim Deleted
Dec 22, 2003
Correspondence Received In Law Office
Dec 23, 2003
Email Received
May 14, 2003
Unresponsive/Duplicate Paper Received
Jul 3, 2003
Non-Final Action Mailed
Apr 10, 2003
Correspondence Received In Law Office
Apr 10, 2003
Paper Received
Feb 25, 2003
Letter Of Suspension Mailed
Feb 24, 2003
Assigned To Examiner
Dec 23, 2002
Paper Received
Jun 4, 2002
Correspondence Received In Law Office
Nov 28, 2001
Non-Final Action Mailed
Nov 15, 2001
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24